2016
Pfizer Fellowship
Program
in partnership with
Institute for Pharmaceutical
Industry Fellowships
Introduction to the
Pfizer Fellowship Program
TABLE OF CONTENTS
Greetings from Freda Lewis-Hall . . . . . . . . 2
Overview of Pfizer, Inc. . . . . . . . . . . . . . . 3
Pfizer’s Global Commercial
Organization Structure . . . . . . . . . . . . . . 4
Pfizer’s OWNIT! Culture . . . . . . . . . . . . . 5
Recruiting Positions for 2016 . . . . . . . . . . 7
Global Medical Information (GMI)
and Global Medical Affairs (GMA) in
Global Innovative Pharma (GIP)
Pfizer Consumer Healthcare (continued)
Overview of Global Medical Information
and Global Medical Affairs . . . . . . . . . . 15
Global Medical Franchise (non-recruiting)
Current Fellows and Preceptors . . . . . . . 26
GMI / GMA Fellowship Description . . . . . 16
GMI / GMA Fellowship: Year 1 . . . . . . . . 17
Global Medical Affairs
Current Fellow and Preceptor . . . . . . . . . 25
Regulatory Affairs Fellowship Overview . . . 27
Overview of Pfizer Oncology . . . . . . . . . . . 9
GMI / GMA Current Preceptors . . . . . . . . 19
Rutgers Pharmaceutical Industry
Fellowship Program
Oncology Medical Affairs
Oncology Fellowship Description . . . . . . . 10
Pfizer Consumer Healthcare (PCH)
Professional Development Series . . . . . . . 30
Medical Affairs
Current Fellows and Preceptor . . . . . . . . 11
Overview of
Pfizer Consumer Healthcare . . . . . . . . . . 20
Key Features . . . . . . . . . . . . . . . . . . . 31
Development & Training . . . . . . . . . . . . 21
Application and
Eligibility Requirements . . . . . . . . . . . . 32
Global Established Pharma
Business (GEP)
Clinical Research & Development
Fellowship Overview . . . . . . . . . . . . . . 22
Alumni Spotlight . . . . . . . . . . . . . . . 33
Overview of
Global Established Pharma . . . . . . . . . . 12
Clinical Research & Development
Current Fellows, Preceptors
and Stakeholders . . . . . . . . . . . . . . . . 23
Pfizer Oncology
GEP Medical Affairs
Fellowship Description . . . . . . . . . . . . . 13
GEP Medical Affairs
Current Fellows and Preceptors . . . . . . . . 14
GMI / GMA Fellowship: Year 2 . . . . . . . . 18
Program History . . . . . . . . . . . . . . . . . 29
Clinical Medical Affairs
Fellowship Overview . . . . . . . . . . . . . . 24
2016 PFIZER FELLOWSHIP PROGRAM
1
Introduction to the
Pfizer Fellowship Program
GREETINGS FROM FREDA LEWIS-HALL
I would like to extend a warm welcome to our partners at Rutgers University and to those candidates
who are considering the Rutgers Pharmaceutical Industry Fellowship (RPIF) Program.
One of Pfizer’s strengths is found in the many talented colleagues in Clinical Research, Medical Affairs,
and Global Franchise Medical who support biomedical innovation and patient safety. As you will read in
the coming pages, Pfizer has a partnership with Rutgers and greatly supports the RPIF program, through
which Fellowship Alumni have gone on to a wide range of leadership opportunities within Pfizer—
and our industry. We are proud that we are offering a Fellowship this year in Clinical Research within
Consumer Healthcare, as well as positions in Medical Affairs in Oncology.
Through this process, we invite you on a journey of personal and professional exploration. You will come
to learn that Pfizer colleagues are among the best in our industry and totally dedicated to better health
outcomes for more of the world’s people.
I wish you great success throughout this process and in your future endeavors.
Sincerely,
reda Lewis-Hall, MD
F
Executive Vice President & Chief Medical Officer
Pfizer Inc
2016 PFIZER FELLOWSHIP PROGRAM
2
Introduction to the
Pfizer Fellowship Program
OVERVIEW OF PFIZER, INC.
Mission Statement
To be the premier,
innovative
biopharmaceutical
company
Pfizer Collegeville, PA
Working Together for
a Healthier World
Our diversified global health
care portfolio includes human
and small molecule medicines
and vaccines, as well as many
of the world’s best-known
consumer products.
unparalleled resources and
world-class facilities as well
as the opportunity to work
on groundbreaking research.
We are dedicated to hiring,
retaining and inspiring our
colleagues by offering some of
the best growth opportunities
available in the industry.
Pfizer encourages and
rewards a culture of idea
sharing, critical thinking, and
continuous improvement.
Each position at Pfizer touches
and contributes to the success
of our business and our world.
This is the reason Pfizer is
committed to hiring highly
qualified candidates for all
areas of our business. We
celebrate the differences that
create the mosaic culture of
Pfizer, especially the diversity
of thought. We nurture these
individuals with access to
Pfizer is focusing unparalleled
scientific and financial
resources on discovery,
development, and delivery of
medicines that people need.
As the ever changing pace of
healthcare around the world
continues to accelerate, we
are evolving by adapting
to our stakeholders’
needs. Consistent with
our responsibility as
the world’s leading
biopharmaceutical company,
we are collaborating with
health care providers,
governments and
local communities
to support and
expand access to
reliable, affordable
health care around
the world. Pfizer will
succeed by being
customer-focused,
entrepreneurial,
and agile.
For more than 150 years, Pfizer
has worked to make a difference
for all who rely on us.
Locations:
Pfizer
Consumer Healthcare HQ
Madison, NJ
Pfizer, NYHQ
235 East 42nd Street
New York City, New York 10017
Pfizer Consumer Healthcare HQ
1 Giralda Farms
Madison, NJ 07940
Pfizer, Collegeville
500 Arcola Rd.
Collegeville, PA 19426
Pfizer NYHQ
2016 PFIZER FELLOWSHIP PROGRAM
3
Introduction to the
Pfizer Fellowship Program
PFIZER’S GLOBAL COMMERCIAL
ORGANIZATION STRUCTURE
Global Commercial Business
Our operating structure represents the next steps in Pfizer’s journey
to further revitalize our innovative core, enhance the value of our
consumer and off-patent established brands and maximize the
use of our capital to deliver value to patients and our shareholders.
Through this evolution, we are enabling greater independence,
focus and responsiveness for our commercial business.
Vaccines,
Oncology &
Consumer
Healthcare
Global
Innovative
Pharma
„„
Inflammation/
Immunology
Global
Established
Pharma
„„
Vaccines
„„
LOE Products
„„
Oncology
„„
Biosimilars
„„
Consumer
Healthcare
„„
EP/EM
Collaborations
„„
CV/Metabolic
„„
Neuroscience
„„
Pain
{{ Mylan in Japan
„„
Rare Diseases
{{ Hisun in China
„„
Men’s/Women’s
Health
{{ Teuto in Brazil
Generally includes
products that are
expected to have
exclusivity beyond 2015
Includes businesses
with different operating
models and distinct
specializations
Global Established
Pharma Business
Includes LOE products
and generally the patentprotected products that
are expected to lose
exclusivity through 2015
2016 PFIZER FELLOWSHIP PROGRAM
Global Innovative
Pharma Business
Worldwide Research
& Development
Pfizer
Global Supply
Vaccines,
Oncology and
Consumer
Business
Enabling
Functions
4
Introduction to the
Pfizer Fellowship Program
PFIZER’S OWNIT! CULTURE:
A CULTURE EMBEDDED IN THE BUSINESS
Pfizer understands that for prospective colleagues, a company’s
internal culture is as important as its external reputation. With
its emphasis on “ownership”, Pfizer’s OWNIT! culture allows
individual colleagues to discover career success at the same time
that it drives positive business results.
OWNIT! encourages all colleagues to take ownership for their careers and make
a positive impact on the business. This means that innovation and new ideas are
met with openness and careful consideration, not skepticism and dismissal. It
means everyone, no matter what their role, strives for excellence. Pfizer colleagues
take accountability for their work and deliver on their commitments with speed,
decisiveness and integrity.
Pfizer’s OWNIT! culture is about all of our colleagues striving to impact results… this
month, this quarter, this year and for many years in the future.
customer
customer
focusfocus
community
community
respect
respect
for people
for people
customer
customer
customer
focusfocus
focuscommunity
community
communityrespect
respect
for
respect
people
for people
for people
customer
customer
customer
focusfocus
focuscommunity
community
community respect
respect
for
respect
people
for people
for people
customer focus
customer focus
community
community
respect for people
performance
collaboration
performance
performance collaboration
collaboration
performance
performance
performance collaboration
collaboration
collaboration
performance
collaboration
leadership
leadership
integrity
integrity
integrity
integrity
quality
performance
performance
performance
respect for
people
quality
quality
quality
leadership
leadership
leadership
integrity
integrity
integrity
integrity
quality
collaboration
leadership
leadership
leadership
leadership
leadership
integrity
integrity
quality
quality
quality
collaboration
collaboration
quality
quality
innovation
innovation
innovation
innovation
innovation
innovation
O
W
N
I
T
own… the
business
win… in the
marketplace
no jerks…
let’s discuss
behaviors
impact…
results
trust… in one
another
innovation
innovation
innovation
innovation
2016 PFIZER FELLOWSHIP PROGRAM
5
Introduction to the
Pfizer Fellowship Program
Pfizer
PFIZER’S OWNIT! CULTURE:
A CULTURE EMBEDDED IN THE BUSINESS
2016 PFIZER FELLOWSHIP PROGRAM
OWNIT!
6
Introduction to the
Pfizer Fellowship Program
RECRUITING POSITIONS FOR 2016
NEW YORK CITY, NY
MADISON, NJ
Medical Affairs
Oncology
1 Year
Clinical Research & Development
Pfizer Consumer Healthcare
2 Years
Medical Affairs
Global Established Pharma
1 Year
Global Medical Affairs
Pfizer Consumer Healthcare
2 Years
Global Medical Information/Global
Medical Affairs
2 Years
2016 PFIZER FELLOWSHIP PROGRAM
Regulatory Affairs
Pfizer Consumer Healthcare
2 Years
7
Introduction to the
Pfizer Fellowship Program
2016 PFIZER FELLOWSHIP PROGRAM
8
Introduction
to
the
Pfizer
Oncology
Pfizer Fellowship Program
OVERVIEW OF
PFIZER ONCOLOGY
At Pfizer Oncology, our focus is on working together with our partners
in the oncology community to find ways to cure or control cancer Our
scientists and researchers working in state-of-the-art labs are focused
on the discovery and development of novel compounds
As science in oncology
continues to evolve, Pfizer is
pursuing research centered
around a personalized
approach to cancer
treatment and tailoring
therapy based on the
molecular and/or biologic
make-up of the disease.
Currently, our portfolio
includes six products
approved by the FDA for
use in the United States. We
also have a robust pipeline
consisting of a number of
biologics and small molecules
in various stages of clinical
development. Supporting this
development are teams of
dedicated people focused on
understanding the specific
needs of patients with cancer
and providing support to
oncology investigators and
practitioners on the front line.
Among these highly matrixed
teams is Medical Affairs,
which plays an integral role in
drug development.
Ivan P. Levinson, MD
North American Lead for
Oncology Medical Affairs
2016 PFIZER FELLOWSHIP PROGRAM
From Pfizer’s global
headquarters in New York
City, Medical Affairs enables
physicians to help patients
by providing data about our
approved products as well as
those investigational products
in our research pipeline. We
manage internal and external
medical communications,
provide medical leadership
in the development of new
and improved treatment
paradigms, and generate
and handle powerful health
outcomes-based data.
We also partner with our
cross-functional colleagues
to ensure clinical trial and
reimbursement strategies are
optimized for the successful
launch of our newest products.
As the healthcare industry
becomes more data-driven,
Medical Affairs has expanded
to three vital areas:
„„
Generating critical
post-launch safety
and efficacy data
to demonstrate the
effectiveness and value
of our medicines
„„
Collaborating with
investigators to improve
cancer treatment by
providing medications for
experimental studies
„„
Helping physicians to
improve the current
standard of care
The next critical step is
communicating medical
information broadly to reach
the oncologists, healthcare
providers, and patients who
really need it. We respond to
questions in the field, provide
expert assistance at most
medical congresses, and
publish the kind of groundbreaking research that
showcases Pfizer’s leadership
in cancer research.
9
Introduction
to
the
Pfizer
Oncology
Pfizer Fellowship Program
ONCOLOGY MEDICAL
AFFAIRS FELLOWSHIP
OVERVIEW
The purpose of this one-year fellowship program
is to provide PharmDs with the skills and
experience to launch a successful career in the
pharmaceutical industry through specialized
training in Oncology Medical Affairs.
The Pfizer Oncology Medical Affairs Fellowship offers a broad
overview of important areas within the pharmaceutical industry,
from clinical trial design and site selection to how we respond
to the needs of practicing oncologists. This broad exposure will
also provide valuable networking opportunities for PharmDs.
Fellows will expand their clinical knowledge through active
participation on the Oncology US Medical Affairs team. Fellows
will also be expected to work closely with Medical Directors and
provide support in the development and execution of a broad
range of medical affairs activities.
2016 PFIZER FELLOWSHIP PROGRAM
The fellowship program emphasizes
three main areas of development:
DEVELOP CRITICAL
INTERACTION SKILLS
AND BUILD A NETWORK
„„
Collaborate across
cross-functional teams
including marketing,
regulatory affairs, public
affairs, communications,
outcomes research, and
clinical research
„„
Attend scientific and
medical conferences and
report on key findings
„„
Interact with key
medical opinion leaders
and other health care
practitioners
„„
Support key collaboration
with Outcomes Research
team to develop strategy,
implement studies, and
interpret data
TRANSFER KNOWLEDGE
AND BECOME A VALUED
TEAM MEMBER
„„
Provide insight to team
members regarding
current practices and
potential future
paradigm shifts
„„
Provide input into the
development of medical
publications, ensuring
that manuscripts are
scientifically accurate
„„
Provide medical review of
promotional materials
„„
Participate in medical
slide development and
review, including training
documents for fieldbased colleagues
GAIN EXPERIENCE IN
THE OPERATIONAL
ASPECTS OF INDUSTRY
„„
Assist in coordination
and planning of advisory
board meetings
„„
Review of investigatorled research proposals
„„
Research, create, and
review medical response
letters and dossiers in
order to develop fair and
scientifically balanced
responses to medical
inquiries
„„
Partner with fieldbased Medical
colleagues in supporting
investigator-led studies,
communicating with
health care professionals,
and supporting research
activities
There will also be
opportunities to gain
experience through rotations
in health economics and
outcomes research, medical
information, and medical
communication.
10
Introduction
to
the
Pfizer
Oncology
Pfizer Fellowship Program
ONCOLOGY MEDICAL AFFAIRS:
CURRENT FELLOWS AND PRECEPTOR
PAST FELLOW
TESTIMONIAL
“The Rutgers Fellowship program provides
a platform for fellows to develop as future
professionals within their respective companies
while collaborating with colleagues and faculty
at Rutgers University.”
Bryan Murray, PharmD, MBA
Manager, Medical Information
Pfizer Medical
Rutgers Fellowship
2014-2015”
Left to Right
FELLOWS
Kristin Jarrell, PharmD
Medical Affairs in Oncology
Audrey Schnell, PharmD
Medical Affairs in Oncology
PRECEPTOR
Marc Chioda, PharmD
Medical Director, Oncology
2016 PFIZER FELLOWSHIP PROGRAM
11
Introduction
to
the
Global Established
Pharma
(GEP)
Pfizer Fellowship Program
OVERVIEW OF
GLOBAL ESTABLISHED PHARMA (GEP)
Global Established Pharma (GEP) is a dynamic and highly-diverse business with
unique opportunities for growth across a portfolio of several hundred products.
We represent more than half
of Pfizer’s total revenues,
and are comprised of four
different portfolio segments:
„„
„„
„„
Medicines that will
shortly go off patent in
developed markets (also
known as Peri-Loss of
Exclusivity (LoE)
„„
Growth opportunities
such as biosimilars, sterile
injectables, and surgicals,
as well as partnerships in
key markets and targeted
opportunities in the
developed markets
Our work spans across the
following therapeutic areas:
Older established
medicines that are
off-patent in
developed markets
„„
CV/Metabolic
„„
CNS
„„
Pain/Inflammatory
Older established
medicines in
emerging markets
„„
Women’s Health
„„
Anti-Infectives
2016 PFIZER FELLOWSHIP PROGRAM
Our strategic intent is
to make a meaningful
contribution to improving
global health through:
„„
The quality and “fit”
of our portfolio to the
needs of our customers
„„
Innovative customer
engagement and service
„„
The diversity, talent,
entrepreneurial spirit
and integrity of our
colleagues
We have a truly global
footprint, with significant
areas of growth both
in emerging and
developed markets.
GEP Global &
Clinical Medical
Affairs Vision
To maintain and improve
the health of more and more
people of all ages worldwide
12
Introduction
to
the
Global Established
Pharma
(GEP)
Pfizer Fellowship Program
MEDICAL AFFAIRS
FELLOWSHIP OVERVIEW
Fellows will develop
in the following
key areas:
The purpose of this one year fellowship is to provide
PharmDs with not only a comprehensive foundation
in Medical Affairs, but also the skill set to launch a
successful career in the pharmaceutical industry.
PROMOTIONAL
OVERSIGHT
This one-year fellowship is designed to facilitate understanding
of both the strategic and operational aspects of Medical
Affairs within the Global Established Pharma Business Unit. The
fellowship will afford PharmDs with the unique experience and
professional growth associated with the challenges posed in a
global pharmaceutical environment.
In addition to developing strategy and providing support during
the post-LOE and peri-LOE phases, the fellow will also be able to
develop their expertise across multiple disease states including
CV/Metabolic, CNS, Pain/Inflammatory, Women’s Health, and
Anti-Infective therapies.
Fellows will work in broad range of medical affairs activities
and play an integral role by participating on review committees
and educational field medical activities, as well as working with
opinion leaders and key stakeholders on advisory boards.
„„
„„
„„
Provide medical
guidance on commercial
projects including
strategy, material
review, and training
Verify medical content
in promotional materials
for correctness and
medical accuracy
„„
Collaborate across
cross-functional teams
including marketing,
regulatory affairs, public
affairs, communications,
global health and value,
and clinical research
Participate in medical
slide development and
review, including training
documents for
field-based colleagues
Provide input into the
development of medical
publications, ensuring
that manuscripts are
scientifically accurate
„„
PROFESSIONAL
INTERACTIONS
„„
„„
Support key collaboration
with Global Health and
Value teams to develop
strategy, implement
studies, and interpret data
Assist in coordination
and planning of advisory
board meetings
„„
Review of investigatorled research proposals
„„
Research, create, and
review medical response
letters and dossiers in
order to develop fair
and scientifically
balanced responses to
medical inquiries
MEDICAL OVERSIGHT
„„
2016 PFIZER FELLOWSHIP PROGRAM
Provide insight to team
members regarding current
practices and potential
future paradigm shifts
„„
„„
Attend scientific and
medical conferences and
report on key findings
„„
Interact with key
medical opinion leaders
and other health care
practitioners
Partner with field-based
Medical colleagues
in supporting
investigator-led studies,
communicating with
health care professionals,
and supporting
research activities
PROFESSIONAL
DEVELOPMENT
„„
Create new programs,
trainings, and
educational material for
patients and providers
„„
Establish and carry out
a budget for assigned
products
„„
Participate in various
Pfizer-led leadership
training seminars
During the fellowship, Fellows
will also have the opportunity
to rotate throughout various
Clinical and Medical Affairs
teams based on their interests,
including, but not limited to
Clinical Development,
Business Development and
Clinical Pharmacology.
13
Introduction
to
the
Global Established
Pharma
(GEP)
Pfizer Fellowship Program
MEDICAL AFFAIRS FELLOWSHIP:
CURRENT FELLOWS AND PRECEPTORS
Top Row (left to right)
FELLOWS
Pardis Tabrizi, PharmD
Medical Affairs in Global Established Pharma Fellow
Praneeta Nagraj, PharmD
Medical Affairs in Global Established Pharma Fellow
Middle Row (left to right)
PRECEPTOR
Damian Largier, MD
GEP Global Medical Affairs Lead
Pol Vandenbroucke, MD, MBA
GEP Regional Medical Lead North America
Eddie G.M. Power, PhD, MBA
GEP Lead/Senior Director US Medical Affairs
Bottom Row (left to right)
Rahul Bhambri, PharmD
GEP US Medical Director
Gustavo Enrique Rodriguez, PharmD
GEP US Associate Medical Director
2016 PFIZER FELLOWSHIP PROGRAM
14
Global Medical
Introduction
Information
to the/
Global Medical
Pfizer Fellowship
Affairs (GMI/GMA)
Program
OVERVIEW OF GLOBAL MEDICAL INFORMATION AND
GLOBAL MEDICAL AFFAIRS IN GLOBAL INNOVATIVE PHARMA
About Global Medical Information
GMI aims to strengthen Pfizer’s mission and
purpose by ensuring access to information
and knowledge that significantly impacts
patient care.
The mission of GMI is to optimize health outcomes by
providing trusted clinical and scientific product information
to HCPs and patients. Our product expertise and customer
interactions enable us to share valuable insights with our
internal partners and to develop innovative solutions that
support the MI needs of our customers.
Medical Information has a global footprint and is part of
Pfizer’s External Medical Communications (EMC) division.
EMC and GMI work to ensure that Pfizer speaks with a
single, strong, medical voice everywhere we serve patients
in order to maximize the medical impact of our products.
GMI achieves this through state-of-the-art medical
information services.
2016 PFIZER FELLOWSHIP PROGRAM
About Global Medical Affairs-Global
Innovative Pharma
Global Innovative Pharma (GIP) is focused on
developing, registering and commercializing
novel, value-creating medicines that significantly
improve patient’s lives.
The purpose of GIP-Global Medical Affairs is to create,
demonstrate, and communicate the clinical value of our
medicines whilst maintaining the primacy of patient’s best
interests. Our mission is to enhance the knowledge of our
medicines and the associated therapeutic areas in which we
focus our research efforts and interpret emerging scientific
trends, clinical data and the competitive landscape and align
internal stakeholders on a balanced benefit-risk proposition.
The GIP-Global Medical Affairs group communicates with
the medical and scientific communities in an accurate, fair
and balanced manner about the benefits and the risks of our
medicines enabling prescribers and other healthcare decision
makers to make informed decision with patients and use our
medicines safely and effectively. We champion patients’
interests by ensuring that improving patients’ lives remains the
primary focus of everything we do at Pfizer.
15
Global Medical
Introduction
Information
to the/
Global Medical
Pfizer Fellowship
Affairs (GMI/GMA)
Program
GMI / GMA FELLOWSHIP
OVERVIEW
1 Two-Year Fellowship in GMI/GMA
Building a Strong Foundation
Development and Networking Opportunities
The GMI/GMA Fellowship is a unique two-year program
that is designed to provide customized and practical
learning opportunities that will provide a comprehensive
foundation and advanced experience that will enable the
Fellow to prepare for a strong career in the pharmaceutical
industry. The first year will be focused in Global Medical
Information and the second year will be focused in Global
Medical Affairs within Global Innovative Pharma.
The Global Medical Information and Global Medical Affairs—Global Innovative
Pharma Fellowship will afford the Fellow opportunities to develop and exhibit
medical professionalism and build a network of industry colleagues.
2016 PFIZER FELLOWSHIP PROGRAM
The Fellow will participate in relevant corporate training programs that are
focused on building medical professionalism and leadership.
The Fellow will interact with and build a network of Pfizer colleagues in crossfunctional global and regional areas that may include (but not be limited to):
„„
Medical Affairs
„„
Commercial
„„
Market Research
„„
Legal
„„
Public Affairs
„„
Field-Based Medical
„„
Regulatory Affairs
„„
Outcomes and Evidence
„„
Independent Grants for Learning and Change
„„
Innovative Research Collaborations
16
Global Medical
Introduction
Information
to the/
Global Medical
Pfizer Fellowship
Affairs (GMI/GMA)
Program
GMI / GMA FELLOWSHIP
OVERVIEW
The GMI year of the Fellowship program is focused on development
of expertise in the following areas:
Global Medical Information Year 1 (2016-2017)
UNDERSTAND
the medicine, therapeutic
area, and the information
needs of the medical
community, patients,
and caregivers:
„„
„„
2016 PFIZER FELLOWSHIP PROGRAM
Develops and leverages
expertise as a subject
matter expert for
assigned Pfizer product(s)
and associated
therapeutic area(s)
Proactively analyzes
inquiry data to identify
customer insights,
trends and subsequently
constructs and executes
strategic action plans as
appropriate when key
medical and customer
issues are identified
GENERATE
valued clinical and
scientific responses to
assist in making informed
healthcare decisions
„„
Performs in-depth
research, analysis,
and interpretation of
the medical literature
from both external and
internal sources
„„
Researches assigned
escalated medical
information inquiries
including utilization
of medical resources,
clinical knowledge, and
the scientific literature
„„
Actively participates in/
leads the creation and
maintenance of regional
and global MI scientific
response documents by
ensuring that responses
are medically and
scientifically accurate,
timely, fair balanced, and
meet customers’ needs
COMMUNICATE
to customers and
stakeholders to facilitate the
safe and effective use of Pfizer
Prescription products:
„„
Provides balanced, scientific,
and evidence-based answers
to unsolicited medical
questions from our customers
„„
Actively participates and
interacts with medical
colleagues (Medical
Affairs and Field-Based
Medical) and crossfunctional team members
(Regulatory Affairs,
Corporate Counsel, Media
Relations, Commercial)
and contributes to the
management of product
issues/crises/business objectives
„„
Participates in strategic
initiatives designed to
enhance the delivery of
medical information through
digital channels
17
Global Medical
Introduction
Information
to the/
Global Medical
Pfizer Fellowship
Affairs (GMI/GMA)
Program
GMI / GMA FELLOWSHIP
OVERVIEW
The GMA-GIP year of the Fellowship program is focused on
developing a broad exposure to the following within the
Cardiovascular / Metabolic therapeutic area:
Global Medical Affairs
Year 2 (2017-2018)
UNDERSTAND
the medicine, therapeutic
area and customer
perspectives:
„„
„„
2016 PFIZER FELLOWSHIP PROGRAM
Understand and interpret
clinical data, emerging
scientific trends and the
competitive landscape
and align internal
stakeholders on a
balanced benefit-risk
proposition
Partner with key thought
leaders, professional
societies, patient and
disease advocacy groups
to better understand
and gain insights into
areas of unmet medical
need for patients and
help shape life-cycle
management strategies
GENERATE
inform the creation,
acquisition, evaluation &
integration of clinical data
and content:
„„
Participate in publication
subcommittee meetings
to plan and implement
appropriate publication
strategies and tactics for
the medicine
„„
Proactively collaborate in the
development and review
of promotional materials
„„
Assist in the development
of medical content for
congresses, symposia,
speaker training and
advisory boards
„„
Assist in the development
of a life-cycle management
strategy that improves the
clinical care of patients by
addressing unmet medical
needs through various
channels (ex. phase IV
trials, investigator-initiated
research (IIRs), real world
data, etc.)
COMMUNICATE
in an accurate, fair and
balanced manner the
benefit-risk, appropriate
use & clinical value of our
medicines:
„„
Serve as a reliable,
trusted resource for
accurate, current medical
and scientific knowledge
(e.g.: disease states,
product label), including
competitive medicines,
for internal and external
stakeholders and
customers
„„
Develop communication
tools that provide
an accurate, fair and
balanced perspective of
our medicines enabling
prescribers and other
healthcare decision
makers to make informed
decisions with patients
and use our medicines
safely and effectively
18
Global Medical
Introduction
Information
to the/
Global Medical
Pfizer Fellowship
Affairs (GMI/GMA)
Program
GMI / GMA FELLOWSHIP:
CURRENT PRECEPTORS
Global Medical Information
(First Row, left to right)
Allison Soloff, PharmD
Director, Medical Information
AnnaMaria D’Ascoli, PharmD, MBA
Senior Manager, Medical Information
Global Medical Affairs
(Second Row, left to right)
Younos Abdulsattar, PharmD, BCPS
Medical Director, Global Medical Affairs, GIP
Dave DeMicco, PharmD
CV/Metabolic Medical Affairs Lead, Global Medical Affairs, GIP
Lisa Tarasenko, PharmD, MBA
Senior Medical Director, Global Medical Affairs, GIP
2016 PFIZER FELLOWSHIP PROGRAM
19
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
OVERVIEW OF
PFIZER CONSUMER HEALTHCARE
Pfizer Consumer Healthcare products support
millions of people daily in more than 90 countries
by enhancing their well-being.
Whether it is promoting
wellness, relieving symptoms or
alleviating pain, our products
are among the world’s leading
non-prescription brands,
including – Advil, Caltrate and
Centrum – that are the #1
products in the world in their
respective categories.
As an integral business unit
of Pfizer Inc., PCH’s success is
grounded in superior science,
built on expert leadership and
accelerated by innovation
at each step of the research,
development, regulatory and
marketing process.
Today, consumers are
becoming more empowered
to manage their personal
well-being, consequently,
PCH’s iconic brands are
leading the way in providing
accessible, affordable and
trusted OTC self care products
to consumers worldwide.
Clinical Research
& Development,
Medical Affairs,
and Regulatory
Pfizer Consumer Healthcare,
in partnership with the Ernest
Mario School of Pharmacy at
Rutgers University, is offering
two year pharmaceutical
industry fellowships in clinical
research and development,
medical affairs, and
regulatory. The first year will
focus on obtaining a well-
2016 PFIZER FELLOWSHIP PROGRAM
rounded foundation in the
fellow’s respective area, and
the second year will provide
the opportunity to rotate
to different departments
based on interest. The
fellows will experience indepth, hands-on training
and work among crossfunctional teams – learning
and developing relationships
with regulatory, product
development, marketing,
project management and
legal colleagues. There will
also be opportunities to
attend conferences and
seminars for continued
education and networking
with industry professionals.
PCH’s fellowship program
is designed to develop the
communication, management
and technical skills that are
the solid foundation for
a successful career in the
pharmaceutical field.
Pfizer Consumer Healthcare Mission
At PCH we have a passion to improve the lives of
people around the world, by empowering them
to take health and wellness into their own hands
through the innovation and expertise of Pfizer.
20
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
DEVELOPMENT & TRAINING
Conducting a clinical trial or communicating with healthcare
providers are integral processes that involve multiple
departments across the organization.
Stakeholders
Not Pictured
To assist fellows in understanding this process, we connect them with
advisors who are leading the cross-functional collaborations. Fellows
will have the opportunity to work closely with the advisors and immerse
themselves into the work and teams of the different departments. The
advisors will serve as educators, mentors and guides to fellows as they
receive hands-on training and develop professionally.
Left to Right
Juby Jacob-Nara, MD, MPH, MBA
Chief Medical Officer & Vice President of
Global Clinical Development & Medical Affairs
Josephine Fubara, PhD
Vice President, Global R&D Franchise Lead, GI
Peter John Ramsey, PhD
Senior Vice President, Senior VP of Global Health
Michael Bailey
Head of Regulatory Affairs, North America & Rx-to-OTC Switch
Program Director for Pfizer Pharmaceutical Industry
Fellowship Program
2016 PFIZER FELLOWSHIP PROGRAM
21
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
CLINICAL RESEARCH & DEVELOPMENT
FELLOWSHIP OVERVIEW
Fellows who pursue a position in PCH’s Global Clinical Research and
Development Department as their core rotation will develop the
following expertise:
„„
Execute clinical trial
programs according
to established quality
standards (Good Clinical
Practices (GCP), external
guidelines / regulations,
and internal processes)
and agreed upon budget
and time lines
{{ Develop innovative
study models to align
with commercial and
regulatory goals for
product launch
{{ Communicate study
{{ Generate and store
relevant documents for
study in collaboration
with regulatory, clinical
development, and
franchise functional
groups
{{ Present protocols
at Investigators’
meetings and Study
Initiation meetings
{{ Serve as the study
clinician on clinical
studies and work with
Clinical Operations
requirements and
updates to team for
efficient progress of
clinical development
programs in the fastpaced market of
consumer healthcare
2016 PFIZER FELLOWSHIP PROGRAM
„„
Provide clinical strategy,
i.e., required clinical
studies, to obtain product
approval in multiple
countries
{{
Write clinical study
reports and clinical
efficacy and safety
sections of regulatory
documents
{{ Prepare for and attend
meetings with FDA
and other regulatory
authorities
„„
Support success of Pfizer
Consumer Healthcare
{{ Partner with Rx-to-
OTC Switch teams
to develop new, first
in class self-care
therapies
{{ Assist senior personnel
in the preparation of
reports for oral/written
delivery at internal and
external meetings
This fellowship is designed to
facilitate understanding both
on strategic and operational
aspects of clinical research.
The fellow will be involved
in the development of OTC
products, medical devices and
Rx-to-OTC switches in various
therapeutic areas including
pain management, respiratory,
GI and personal care.
During the second year of
the fellowship, individuals will
have the option to complete a
rotation with the Therapeutics
Franchise Teams, the Rx to
OTC Switch Team, or may
delve into other areas such
as Regulatory Affairs, Project
Management or Marketing.
22
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
CLINICAL RESEARCH & DEVELOPMENT FELLOWSHIP:
CURRENT FELLOWS, PRECEPTORS,
AND STAKEHOLDERS
Top Row (left to right)
FELLOWS
Edmund Arthur, PharmD
Clinical Research & Development Fellow
Vani Kumaran, PharmD
Clinical Research & Development Fellow
Middle Row (left to right)
PRECEPTORS
Mario Cruz-Rivera, PhD, MPH, FCAAAI, FAAAAI
Senior Director, Global Clinical Research & Rx-to-OTC Switch
David Savastano, PhD
Director, Clinical Research
Bottom Row (left to right)
STAKEHOLDERS
James T. Angello, PharmD
Senior Director, Global Clinical Research
Anne LeMoigne
Senior Director, Clinical Excellence & Biometrics
Lisa A. Baird, MS
Senior Director, Clinical Operations
2016 PFIZER FELLOWSHIP PROGRAM
23
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
GLOBAL MEDICAL AFFAIRS
FELLOWSHIP OVERVIEW
Fellows who pursue a position in PCH’s Global Medical Affairs department
as their core rotation will:
„„
Have involvement
with key healthcare
providers in exchange
of scientific and medical
ideas including Advisory
Boards and presentations
at national meetings
„„
Provide medical guidance
on commercial projects
including strategy,
material review and
training
„„
Facilitate
communications
between PCH Medical
and the Study
Investigators, and
oversee the publication
of clinical trial results
both at scientific
meetings and in peer
reviewed journals
„„
„„
Initiate and build
collaborations with other
business units within
Pfizer on projects of
mutual scientific interest
and integrate joint
medical activities and
initiatives
Collaborate with
Worldwide Safety
Strategy in setting the
overall safety strategies
and providing benefit-risk
assessments for PCH’s
portfolio of products
2016 PFIZER FELLOWSHIP PROGRAM
„„
Collaborate with the
commercial unit and
provide scientific input
for the development and
review of promotional
materials, documents
and presentations
developed for the
assigned drugs and/or
indications
„„
Develop relevant parts
of the medical affairs
tactical plans, and/
or complete other
special projects such as
preparation and review
of training materials for
field forces
„„
Coordinate and liaise
with internal and
external providers for
data mining activities
„„
Provide data outputs
requested for safety and/
or other relevant sections
of IND annual reports,
if these sections and
reports relate to assigned
drugs and/or indications
„„
Coordinate the
preparation of, and
review data outputs for,
reporting documents
where appropriate (e.g.
clinical study reports,
analysis plans, etc.)
with the Contract
Research Organization,
the Biostatisticians
and Clinical Research
colleagues
This fellowship is designed
to facilitate understanding
of both the strategic and
operational aspects of global
medical affairs across various
therapeutic areas, including
pain management, dietary
supplements, respiratory, GI
and personal care.
During the second year of
the fellowship, individuals will
have the option to work more
closely with the Therapeutics
Franchise teams, the
Rx-to-OTC Switch team, or
depending upon interest,
Regulatory Affairs, Project
Management or Marketing.
24
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
GLOBAL MEDICAL AFFAIRS:
CURRENT FELLOW AND PRECEPTOR
FELLOW
Unicel-Anne Flores, PharmD
Global Medical Affairs Fellow
PRECEPTOR
Bill Bailey, PharmD
Head of North America,
Medical Affairs
2016 PFIZER FELLOWSHIP PROGRAM
25
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
GLOBAL MEDICAL FRANCHISE:
CURRENT FELLOWS AND PRECEPTORS
Top Row (left to right)
FELLOWS
Alexander Schepart, PharmD, MBA
Pain Global Medical Franchise Fellow
Agnes Hong, PharmD
GI Global Medical Franchise Fellow
Bottom Row (left to right)
PRECEPTORS
David Kellstein, PhD
Senior Director, R&D Pain Management
Charles Pollack, MD, PhD
Senior Director, GI Medical Franchise
GLOBAL MEDICAL FRANCHISE IS
NOT RECRUITING FOR 2016
2016 PFIZER FELLOWSHIP PROGRAM
26
Introduction
to
the
Pfizer
Consumer
Healthcare
Pfizer Fellowship Program
REGULATORY AFFAIRS
OVERVIEW
Whether you have entertained the idea of
academic research or have career aspirations for
business within the pharmaceutical industry, the
scientific discipline of Regulatory Affairs provides
you a unique line of sight to drug development
process, giving rise to the opportunity to touch
on every aspect of research and development
as well as engage with key business disciplines
throughout the lifecycle of a given health or
wellness product.
If you would you like to experience work in a multicultural and
diverse environment of a global healthcare company, then
this program is for you as it will allow you to discover
the multiple touch points of Regulatory Affairs.
Upon selection, you will be offered a place in
our 2-year Regulatory Program, consisting
of rotation assignments within Pfizer
Consumer Healthcare and
broader Pfizer business units.
„„
Some aspects of this program
include the following:
„„
„„
„„
Participate in the Review
and Approval of Labeling
and Advertising &
Promotion across one or
more Therapeutic Areas
Contribute in the
Development of
Regulatory Strategies
for project/product
registrations
and launches
Assist in the
implementation of
training/orientation
programs for onboarding
within and outside of
regulatory strategy
„„
„„
Conduct due diligence on
competitive landscape
of consumer products
and on-package claims,
identifying consistent
and inconsistent
approaches to consumer
messaging of molecule
class within industry
Help facilitate education
of key stakeholders and
cross-functional team
leaders with respect
to regulatory science/
basics for local market
requirements
Gain experience in one or
more Regulatory product
classifications: NDA,
Monograph, Medical
Device, Cosmetic, Dietary
Supplements
„„
Assist in the FDA
product registration
submission process
„„
Assist in solving various
in-market regulatory
issues and concerns
„„
Gain insights into the
Rx-to-OTC Switch
process as well as the
Global, Regional and
Country aspects of
Regulatory Affairs
„„
2 year program; 1st year
within Pfizer Consumer
Healthcare (PCH)
Regulatory Affairs, 2nd
year rotation options in
various functions within
PCH/Pfizer Inc.
PRECEPTOR
Christine Chirdo
Director, US Regulatory Strategy Category Lead,
GI/Respiratory/Personal Care Worldwide Regulatory
2016 PFIZER FELLOWSHIP PROGRAM
27
Rutgers Pharmaceutical Industry
Fellowship Program
Ernesto Mario School
of Pharmacy
Rutgers, The
State University
Introduction
to the
of New
Jersey
Pfizer Fellowship
Program
Ernesto Mario School
of Pharmacy
Rutgers Pharmaceutical Industry
Fellowship Program History
In 1984, at Rutgers, The State University of New
Jersey, the Ernest Mario School of Pharmacy and
two pharmaceutical companies began a collaborative
pilot program to evaluate the potential contributions
of clinically-trained pharmacists within a
pharmaceutical industry practice setting. Following
the successful pilot, the Rutgers Pharmaceutical
Industry Fellowship (RPIF) Program grew
significantly and expanded to include 17 companies
within the pharmaceutical and biopharmaceutical
industries and over 100 fellows annually.
Dr. Michael Toscani
Research Professor, Fellowship Director
Institute for Pharmaceutical Industry Fellowship
2016 PFIZER FELLOWSHIP PROGRAM
In 2002, Dr. Ernest Mario
generously provided an
endowment to establish the
Institute for Pharmaceutical
Industry Fellowships to
enhance and promote
the role of pharmacists in
industry through the RPIF
Program. The Institute
staff members:
„„
provide leadership and
administrative support;
„„
promote quality,
communication, and
scholarly activity; and
„„
arrange specialized
fellowship training
opportunities within
the pharmaceutical
and biopharmaceutical
industries
„„
The RPIF Program
has thrived under the
leadership of the founder,
Dr. Joseph A. Barone,
Dean and Distinguished
Dr. Joseph A. Barone
Dean and Distinguished Professor II
Ernest Mario School of Pharmacy
Professor II of the
Ernest Mario School
of Pharmacy and
Dr. Michael Toscani,
Research Professor and
the Fellowship Director
for the Institute for
Pharmaceutical
Industry Fellowships.
More than 800 postdoctoral fellows have
completed the RPIF
Program, most of whom
are pursuing influential
and rewarding careers in
the pharmaceutical and
biopharmaceutical industries
throughout the US and
abroad. The RPIF Program
has preceptors/mentors from
industry who share their
knowledge and experiences
with the fellows through
an intense but closelyguided training program.
Assignments and projects
are challenging,
meaningful, and designed to
enhance understanding of
the pharmaceutica
and biopharmaceutical
industries and the fellow’s
functional area.
29
Rutgers, The
State University
Introduction
to the
of New
Jersey
Pfizer Fellowship
Program
Ernesto Mario School
of Pharmacy
Professional Development Series
All fellows gather at Rutgers once or twice monthly as a group to participate in the Professional
Development Day (PDD) Series, an important component of their training that complements the hands-on
experience provided at the partner companies.
The PDDs are steered by a committee of fellows and are
designed to enhance the fellows’ presentation skills, promote
connectivity and a sense of community among fellows from
different companies and disciplines, develop new skill sets
under the guidance of external trainers, and provide general
knowledge about various aspects of drug development and
issues facing the pharmaceutical and biopharmaceutical
industries.
The fellows learn from each other through individual and
group presentations and debates on topics and issues related
to the pharmaceutical and biopharmaceutical industries. This
dynamic forum provides an opportunity for open discussion
and debate among fellows, Rutgers faculty, and company
preceptors. In addition, outside experts provide training and
professional development in a variety of areas (e.g., tools for
2016 PFIZER FELLOWSHIP PROGRAM
corporate success; professional writing, presentations, meeting
facilitation, negotiating, influencing, networking, and conflict
resolution skills; giving and receiving feedback; and business
and dining etiquette). Other PDD guest speakers include
industry executives, patient advocacy groups, and successful
RPIF Program alumni who share their insights and experiences.
Importantly, PDDs provide an excellent opportunity for fellows
to interact with each other and develop lasting personal
friendships and a strong professional network of fellows, faculty,
alumni, and other industry executives
30
Rutgers, The
State University
Introduction
to the
of New
Jersey
Pfizer Fellowship
Program
Ernesto Mario School
of Pharmacy
Key Features
F
O
The Rutgers Pharmaceutical Industry Fellowship
Program FOSTERs the growth and development
of future pharmaceutical and biopharmaceutical
industry professionals through the following key
program features:
2016 PFIZER FELLOWSHIP PROGRAM
amily of Leading Companies–Partners include several of the top 17 global
pharmaceutical and biopharmaceutical companies.
utstanding Alumni Track Record–Over 800 alumni hold prominent positions at
many leading companies.
S
trong Network—Over 100 fellows each year develop valuable, lasting connections
with each other, alumni, preceptors.
T
he Pathway to Industry–Since 1984, the Rutgers program has been nationally
recognized, trusted, and proven as the pathway to industry for pharmacists.
E
nhanced Career Path–Increasingly challenging assignments build depth of
experience and enhance the potential for an accelerated career path.
R
igorous Academic Component–Rutgers affiliation provides academic and
professional development opportunities.
31
Rutgers, The
State University
Introduction
to the
of New
Jersey
Pfizer Fellowship
Program
Ernesto Mario School
of Pharmacy
Application Process and Eligibility Requirements
Fellows for the Rutgers Pharmaceutical Industry Fellowship Program are selected on a nationallycompetitive basis. Candidates must have completed a Doctor of Pharmacy degree from an ACPE
accredited institution before July 1 of the fellowship term.
Participation in the ASHP Midyear Clinical Meeting/PPS is strongly encouraged. Interested
individuals are invited to electronically submit a letter of intent, curriculum vitae, and three
letters of recommendation to: ifellows@pharmacy.rutgers.edu
Please address all correspondence to:
Joseph A. Barone, PharmD., F.C.C.P.
Dean and Distinguished Professor II
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
160 Frelinghuysen Road
Piscataway, NJ 08854-8020
ifellows@pharmacy.rutgers.edu
Application materials may be submitted as early as November 17, and applicants are encouraged
to submit as many of the required materials as possible by December 15. All applicants should
also electronically complete a Program Interest Form at: http://pharmafellows.rutgers.edu
Rutgers University
Piscataway, NJ
2016 PFIZER FELLOWSHIP PROGRAM
32
Introduction
to
the
Alumni
Spotlight
Pfizer Fellowship Program
GUSTAVO ENRIQUE RODRIGUEZ,
PHARMD
GEP US Associate Medical Director
Rutgers Fellowship Class of 2014
“The Rutgers fellowship provided a great foundation
for my career in the pharmaceutical industry.
The experiences and opportunities through my
fellowship have proven to be very valuable towards my
professional development.”
SAJID AHMED, PHARMD
Manager, Aggregate Reports Analyst
Rutgers Fellowship Class of 2015
“The Rutgers Fellowship program provides a platform
for fellows to develop as future professionals within their
respective companies while collaborating with colleagues
and faculty at Rutgers University.”
2016 PFIZER FELLOWSHIP PROGRAM
33
Introduction to the
Pfizer Fellowship Program
www.pfizer.com
2016 PFIZER FELLOWSHIP PROGRAM
35